Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for TWST.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 166.84M
March 31, 2026 171.67M
December 31, 2025 197.95M
September 30, 2025 232.43M
June 30, 2025 250.80M
March 31, 2025 257.15M
December 31, 2024 270.83M
September 30, 2024 276.40M
June 30, 2024 289.42M
March 31, 2024 293.34M
December 31, 2023 311.14M
September 30, 2023 336.41M
June 30, 2023 357.14M
March 31, 2023 387.66M
December 31, 2022 438.71M
September 30, 2022 504.97M
June 30, 2022 527.59M
March 31, 2022 573.86M
Date Value
December 31, 2021 301.86M
September 30, 2021 477.86M
June 30, 2021 519.41M
March 31, 2021 555.66M
December 31, 2020 587.28M
September 30, 2020 290.00M
June 30, 2020 311.84M
March 31, 2020 230.15M
December 31, 2019 103.11M
September 30, 2019 138.19M
June 30, 2019 161.98M
March 31, 2019 104.54M
December 31, 2018 130.22M
September 30, 2018 80.76M
June 30, 2018 92.50M
March 31, 2018
December 31, 2017
September 30, 2017 62.20M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Beam Therapeutics, Inc. 1.153B
Intellia Therapeutics, Inc. 437.76M
Prime Medicine, Inc. 95.07M
Absci Corp. 201.14M
10X Genomics, Inc. 552.03M